Team:Stockholm/5 July 2010

From 2010.igem.org

(Difference between revisions)
(Andreas)
(Andreas)
Line 11: Line 11:
|'''Sample'''
|'''Sample'''
|'''DNA conc (ng/ul)'''
|'''DNA conc (ng/ul)'''
-
|'''A(260)/A(280)'''
+
|'''A<sub>260</sub>/A<sub>280</sub>'''
|-
|-
|pSB1A3.BBa_J04450
|pSB1A3.BBa_J04450

Revision as of 12:58, 6 July 2010


Contents


Andreas

Plasmid preparations

Prepared plasmids from ON cultures.

DNA concentrations

Sample DNA conc (ng/ul) A260/A280
pSB1A3.BBa_J04450 66.8 1.74
pSB1C3.BBa_J04450 36.5 1.87
pSB1AC3.BBa_J04450 41.0 1.95
pSB1AK3.BBa_J04450 10.8 2.64
pMA.BBa_J18930 33.3 1.95
pMA.BBa_J18931 52.5 1.92
pMA.BBa_J18932 34.1 1.99

Part and primer design

I investigated Mimmi's primers, most specifically the ones designed for ligation of our CPPs (TAT, LMWP and Transportan 10). Me and Johan discussed whether we should order them as is, or if we should instead have the genes synthesized. We decided that we should rethink the matter until tomorrow, when we can have a group meeting and discuss this further.

Johan also discovered that several of our genes contain disallowed BioBrick restriction sites:

  • Tyrosinase contains one NgoMIV site at 500 bp.
  • yCCS contains one EcoRI site at 230 bp.
  • bFGF contains one AgeI site at 350 bp.

These need to be removed. We will discuss this tomorrow.

Hassan